Edge Therapeutics Stock Price and Value Analysis

Should you buy Edge Therapeutics stock? (NasdaqGS:EDGE). Let's see how it does in our automated value investing analysis system.

EDGE Free Cash Flow Trend

Free Cash Flow trendline for EDGE
Free Cash Flow trendline for Edge Therapeutics

Hmm, we can't give any reliable projection for Edge Therapeutics's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

  • This company has stable growth.
  • This company is not making money.
  • This company is less known than others.
  • This stock looks overpriced.
  • This company pays no dividend.

Inside the EDGE Numbers

EDGE Price
(Edge Therapeutics stock price per share)
PE Ratio versus Sector 100% lower than other Unknown stocks
PE Ratio versus Industry 57.8% higher than other Unknown stocks
Free Cash Flow Jitter 23%

Is Edge Therapeutics Stock on Sale?

Based on our analysis, we believe that you should not buy Edge Therapeutics right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy EDGE Stock?

Does Edge Therapeutics have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.